Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Artesunate-mefloquine on the Thai-Myanmar Border and the Relative Roles of Resistance Genetic Markers: A Retrospective Cohort Study

NCT02427360 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02427360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02427360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Artesunate-mefloquine on the Thai-Myanmar Border and the Relative Roles of Resistance Genetic Markers: A Retrospective Cohort Study
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
December 31, 2015
Enrollment
1,022 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

p. falciparum malaria, p. falciparum malaria mixed infection